4.7 Article

Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan et al.

Article Gastroenterology & Hepatology

Label-retaining liver cancer cells are relatively resistant to sorafenib

Hong-Wu Xin et al.

Article Hematology

Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis

Purvaba J. Sarvaiya et al.

AMERICAN JOURNAL OF HEMATOLOGY (2012)

Article Biochemistry & Molecular Biology

Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry

Stephen J. Orr et al.

MOLECULAR SYSTEMS BIOLOGY (2012)

Article Multidisciplinary Sciences

Distinct contribution of stem and progenitor cells to epidermal maintenance

Guilhem Mascre et al.

NATURE (2012)

Article Multidisciplinary Sciences

A restricted cell population propagates glioblastoma growth after chemotherapy

Jian Chen et al.

NATURE (2012)

Article Clinical Neurology

Evidence for label-retaining tumour-initiating cells in human glioblastoma

Loic P. Deleyrolle et al.

BRAIN (2011)

Review Oncology

Insight into the complex regulation of CD133 in glioma

Benito Campos et al.

INTERNATIONAL JOURNAL OF CANCER (2011)

Article Cell & Tissue Engineering

Integrin Alpha 6 Regulates Glioblastoma Stem Cells

Justin D. Lathia et al.

CELL STEM CELL (2010)

Article Oncology

Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

Benito Campos et al.

CLINICAL CANCER RESEARCH (2010)

Article Cell & Tissue Engineering

SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma

Myung Jin Son et al.

CELL STEM CELL (2009)

Article Cell & Tissue Engineering

Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma

Dan R. Laks et al.

STEM CELLS (2009)

Article Oncology

Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme

Roberto Pallini et al.

CLINICAL CANCER RESEARCH (2008)

Article Oncology

Stem cell marker CD133 affects clinical outcome in glioma patients

Felix Zeppernick et al.

CLINICAL CANCER RESEARCH (2008)

Article Clinical Neurology

Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas

Alfred T. Ogden et al.

NEUROSURGERY (2008)

Article Cell & Tissue Engineering

Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay

Sharon A. Louis et al.

STEM CELLS (2008)

Article Cell Biology

Borealin is repressed in response to p53/Rb signaling

Dipali A. Date et al.

CELL BIOLOGY INTERNATIONAL (2007)

Article Biochemistry & Molecular Biology

A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2

JL Wang et al.

BIOCHEMICAL JOURNAL (2006)

Article Multidisciplinary Sciences

A distinct side population of cells with high drug efflux capacity in human tumor cells

C Hirschmann-Jax et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Multidisciplinary Sciences

Identification of human brain tumour initiating cells

SK Singh et al.

NATURE (2004)